Compare $ERNA vs $GRI | Chartloom

Compare

$ERNA vs $GRI

Ernexa Therapeutics Inc · GRI Bio Inc

ERNA

Ernexa Therapeutics Inc

GRI

GRI Bio Inc

Compare $ERNA vs $GRI

Comparing Ernexa Therapeutics Inc and GRI Bio Inc

ERNAErnexa Therapeutics Inc

GRIGRI Bio Inc

ERNAErnexa Therapeutics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-91.7%

52W performance

-93.0%

FCF yield

-316.2%

GRIGRI Bio Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-77.8%

52W performance

-96.7%

FCF yield

-338.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ERNA

GRI

Detailed metrics comparison

ERNA

Ernexa Therapeutics Inc

GRI

GRI Bio Inc

Market Cap

ERNA$3M

GRI$3M

Enterprise Value

ERNA$-2M

GRI$-8M

Price

ERNA$2.40

GRI$1.74

P/E Ratio

ERNAN/A

GRIN/A

P/S Ratio

ERNA8.30x

GRI0.00x

EV/Sales

ERNA0.09x

GRI0.00x

EV/EBITDA

ERNA0.00x

GRI0.00x

P/B Ratio

ERNA1.51x

GRI0.42x

P/FCF Ratio

ERNAN/A

GRIN/A

EV/FCF

ERNA0.22x

GRI0.76x

PEG Ratio

ERNAN/A

GRIN/A

Forward P/E (NTM)

ERNAN/A

GRIN/A

Forward P/S (NTM)

ERNAN/A

GRIN/A

Revenue (TTM)

ERNA$0

GRI$0

Revenue Growth (YoY)

ERNAN/A

GRIN/A

Forward Rev Growth

ERNA0.0%

GRI0.0%

Gross Margin (TTM)

ERNA83.5%

GRI0.0%

Operating Margin (TTM)

ERNA0.0%

GRI0.0%

EBITDA Margin (TTM)

ERNA0.0%

GRI0.0%

Net Margin (TTM)

ERNA0.0%

GRI0.0%

FCF Margin (TTM)

ERNAN/A

GRIN/A

Net Income (TTM)

ERNA$-3M

GRI$-10M

FCF (TTM)

ERNA$-9M

GRI$-10M

EPS (TTM)

ERNA$0.00

GRI-$5.35

ROE (TTM)

ERNA-16940.0%

GRI-13403.0%

ROA (TTM)

ERNA-22854.0%

GRI-10683.0%

ROIC (TTM)

ERNA-15802.0%

GRI-13403.0%

Cash

ERNA$5M

GRI$11M

Debt

ERNA$250K

GRI$0

Net Cash/Debt

ERNA$5M

GRI$11M

Current Ratio (TTM)

ERNA2.01x

GRI10.30x

Quick Ratio (TTM)

ERNA1.74x

GRI9.95x

Debt/Equity (TTM)

ERNA0.08x

GRI0.00x

Debt/Assets (TTM)

ERNA0.0%

GRI0.0%

Interest Coverage (TTM)

ERNAN/A

GRIN/A

Net Debt/EBITDA (TTM)

ERNA0.00x

GRI0.00x

Beta

ERNA2.68

GRI-1.09

52W Performance

ERNA-93.0%

GRI-96.7%

YTD Performance

ERNA-91.7%

GRI-77.8%

% from 52W High

ERNA-96.6%

GRI-97.3%

% from 52W Low

ERNA13.2%

GRI27.9%

Asset Turnover (TTM)

ERNA0.02x

GRI0.00x

FCF Yield (TTM)

ERNA-316.2%

GRI-338.3%

Earnings Yield (TTM)

ERNA-97.9%

GRI-313.6%

Dividend Yield (TTM)

ERNA0.4%

GRIN/A

Rule of 40

ERNA0.0

GRI0.0

EV/GP/RG

ERNAN/A

GRIN/A

Ticker research

View ERNA research View GRI research

Metric	ERNA Ernexa Therapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$-2M	$-8M
Price	$2.40	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	8.30x	0.00x
EV/Sales	0.09x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.51x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	0.22x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	83.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-10M
FCF (TTM)	$-9M	$-10M
EPS (TTM)	$0.00	-$5.35
ROE (TTM)	-16940.0%	-13403.0%
ROA (TTM)	-22854.0%	-10683.0%
ROIC (TTM)	-15802.0%	-13403.0%
Financial Health
Cash	$5M	$11M
Debt	$250K	$0
Net Cash/Debt	$5M	$11M
Current Ratio (TTM)	2.01x	10.30x
Quick Ratio (TTM)	1.74x	9.95x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.68	-1.09
52W Performance	-93.0%	-96.7%
YTD Performance	-91.7%	-77.8%
% from 52W High	-96.6%	-97.3%
% from 52W Low	13.2%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-316.2%	-338.3%
Earnings Yield (TTM)	-97.9%	-313.6%
Dividend Yield (TTM)	0.4%	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ERNA research	View GRI research

Valuation

P/S Ratio

GRI

0.00x

ERNA

8.30x

EV/FCF

ERNA

0.22x

GRI

0.76x

Growth & revenue

Forward Revenue Growth

ERNA

0.0%

GRI

0.0%

Profitability & performance

Gross Margin

ERNA

83.5%

GRI

0.0%

ROE

GRI

-13403.0%

ERNA

-16940.0%

FCF Yield %

ERNA

-316.2%

GRI

-338.3%

52-Week Performance

ERNA

-93.0%

GRI

-96.7%

Detailed metrics comparison

ERNA

Ernexa Therapeutics Inc

GRI

GRI Bio Inc

Market Cap

ERNA$3M

GRI$3M

Enterprise Value

ERNA$-2M

GRI$-8M

Price

ERNA$2.40

GRI$1.74

P/E Ratio

ERNAN/A

GRIN/A

P/S Ratio

ERNA8.30x

GRI0.00x

EV/Sales

ERNA0.09x

GRI0.00x

EV/EBITDA

ERNA0.00x

GRI0.00x

P/B Ratio

ERNA1.51x

GRI0.42x

P/FCF Ratio

ERNAN/A

GRIN/A

EV/FCF

ERNA0.22x

GRI0.76x

PEG Ratio

ERNAN/A

GRIN/A

Forward P/E (NTM)

ERNAN/A

GRIN/A

Forward P/S (NTM)

ERNAN/A

GRIN/A

Revenue (TTM)

ERNA$0

GRI$0

Revenue Growth (YoY)

ERNAN/A

GRIN/A

Forward Rev Growth

ERNA0.0%

GRI0.0%

Gross Margin (TTM)

ERNA83.5%

GRI0.0%

Operating Margin (TTM)

ERNA0.0%

GRI0.0%

EBITDA Margin (TTM)

ERNA0.0%

GRI0.0%

Net Margin (TTM)

ERNA0.0%

GRI0.0%

FCF Margin (TTM)

ERNAN/A

GRIN/A

Net Income (TTM)

ERNA$-3M

GRI$-10M

FCF (TTM)

ERNA$-9M

GRI$-10M

EPS (TTM)

ERNA$0.00

GRI-$5.35

ROE (TTM)

ERNA-16940.0%

GRI-13403.0%

ROA (TTM)

ERNA-22854.0%

GRI-10683.0%

ROIC (TTM)

ERNA-15802.0%

GRI-13403.0%

Cash

ERNA$5M

GRI$11M

Debt

ERNA$250K

GRI$0

Net Cash/Debt

ERNA$5M

GRI$11M

Current Ratio (TTM)

ERNA2.01x

GRI10.30x

Quick Ratio (TTM)

ERNA1.74x

GRI9.95x

Debt/Equity (TTM)

ERNA0.08x

GRI0.00x

Debt/Assets (TTM)

ERNA0.0%

GRI0.0%

Interest Coverage (TTM)

ERNAN/A

GRIN/A

Net Debt/EBITDA (TTM)

ERNA0.00x

GRI0.00x

Beta

ERNA2.68

GRI-1.09

52W Performance

ERNA-93.0%

GRI-96.7%

YTD Performance

ERNA-91.7%

GRI-77.8%

% from 52W High

ERNA-96.6%

GRI-97.3%

% from 52W Low

ERNA13.2%

GRI27.9%

Asset Turnover (TTM)

ERNA0.02x

GRI0.00x

FCF Yield (TTM)

ERNA-316.2%

GRI-338.3%

Earnings Yield (TTM)

ERNA-97.9%

GRI-313.6%

Dividend Yield (TTM)

ERNA0.4%

GRIN/A

Rule of 40

ERNA0.0

GRI0.0

EV/GP/RG

ERNAN/A

GRIN/A

Ticker research

View ERNA research View GRI research

Metric	ERNA Ernexa Therapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$-2M	$-8M
Price	$2.40	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	8.30x	0.00x
EV/Sales	0.09x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.51x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	0.22x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	83.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-10M
FCF (TTM)	$-9M	$-10M
EPS (TTM)	$0.00	-$5.35
ROE (TTM)	-16940.0%	-13403.0%
ROA (TTM)	-22854.0%	-10683.0%
ROIC (TTM)	-15802.0%	-13403.0%
Financial Health
Cash	$5M	$11M
Debt	$250K	$0
Net Cash/Debt	$5M	$11M
Current Ratio (TTM)	2.01x	10.30x
Quick Ratio (TTM)	1.74x	9.95x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.68	-1.09
52W Performance	-93.0%	-96.7%
YTD Performance	-91.7%	-77.8%
% from 52W High	-96.6%	-97.3%
% from 52W Low	13.2%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-316.2%	-338.3%
Earnings Yield (TTM)	-97.9%	-313.6%
Dividend Yield (TTM)	0.4%	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ERNA research	View GRI research